
1. j immunol. 2011 jun 15;186(12):6657-60. doi: 10.4049/jimmunol.1100603. epub 2011 
may 13.

cutting edge: membrane attack complex complement required the
development murine experimental cerebral malaria.

ramos tn(1), darley mm, hu x, billker o, rayner jc, ahras m, wohler je, barnum
sr.

author information: 
(1)department microbiology, university alabama birmingham, birmingham,
al 35294, usa.

cerebral malaria severe complication plasmodium falciparum
infection accounts large number malaria fatalities worldwide. recent
studies demonstrated c5(-/-) mice resistant experimental cerebral
malaria (ecm) suggested protection due loss c5a-induced
inflammation. surprisingly, observed c5ar(-/-) mice fully
susceptible disease, indicating c5a required ecm. c3ar(-/-)
and c3ar(-/-) Ã— c5ar(-/-) mice equally susceptible ecm wild-type 
mice, indicating neither complement anaphylatoxin receptor critical for
ecm development. contrast, c9 deposition brains mice ecm
suggested important role terminal complement pathway. treatment with
anti-c9 ab significantly increased survival time reduced mortality ecm.
our data indicate protection ecm c5(-/-) mice mediated through
inhibition membrane attack complex formation c5a-induced
inflammation.

doi: 10.4049/jimmunol.1100603 
pmcid: pmc3110530
pmid: 21572031  [indexed medline]

